Henry Schein, Inc. (NASDAQ:HSIC) – Jefferies Financial Group lowered their Q4 2018 earnings per share estimates for Henry Schein in a research note issued on Wednesday, November 7th. Jefferies Financial Group analyst B. Couillard now expects that the company will post earnings per share of $1.10 for the quarter, down from their prior estimate of $1.13. Jefferies Financial Group also issued estimates for Henry Schein’s Q3 2019 earnings at $1.11 EPS, Q4 2019 earnings at $1.16 EPS and FY2019 earnings at $4.45 EPS.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.02. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The firm had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.37 billion. During the same quarter last year, the business posted $0.87 earnings per share. The firm’s revenue was up 3.8% compared to the same quarter last year.

A number of other equities analysts also recently commented on HSIC. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Wednesday, July 25th. Stifel Nicolaus lifted their price objective on Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a research report on Tuesday, August 7th. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Thursday, July 26th. Barrington Research reiterated a “buy” rating and set a $92.00 price objective on shares of Henry Schein in a research report on Tuesday, August 7th. Finally, Craig Hallum lifted their target price on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Henry Schein currently has an average rating of “Hold” and a consensus target price of $84.41.

Shares of Henry Schein stock opened at $84.92 on Monday. Henry Schein has a one year low of $62.56 and a one year high of $90.52. The company has a market cap of $13.02 billion, a P/E ratio of 23.59, a P/E/G ratio of 2.66 and a beta of 0.87. The company has a current ratio of 1.30, a quick ratio of 0.70 and a debt-to-equity ratio of 0.29.

A number of large investors have recently bought and sold shares of HSIC. FMR LLC raised its position in Henry Schein by 167.3% in the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after purchasing an additional 4,151,179 shares during the period. Point72 Asset Management L.P. raised its holdings in shares of Henry Schein by 2,573.5% in the 2nd quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock valued at $58,261,000 after buying an additional 772,047 shares during the period. Atlanta Capital Management Co. L L C raised its holdings in shares of Henry Schein by 19.0% in the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,924,653 shares of the company’s stock valued at $248,683,000 after buying an additional 466,704 shares during the period. American Century Companies Inc. raised its holdings in shares of Henry Schein by 21.2% in the 2nd quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock valued at $159,202,000 after buying an additional 383,479 shares during the period. Finally, Glenmede Trust Co. NA raised its holdings in shares of Henry Schein by 11,084.6% in the 2nd quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock valued at $25,787,000 after buying an additional 351,826 shares during the period.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: Ex-Dividend

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.